JPRN-UMIN000017149已完成未知
Predictive factors associated with virological response in Daclatasvir and Asunaprevir combination therapy for genotype1b-infected chronic hepatitis C patients : multicenter study - Predictive factors for virological response in Daclatasvir and Asunaprevir combination therapy
ippon Medical School Chiba Hokusoh Hospital0 个研究点目标入组 300 人开始时间: 2015年4月17日最近更新:
适应症
试验速览
- 阶段
- 未知
- 状态
- 已完成
- 发起方
- 入组人数
- 300
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 18years-old 至 85years-old（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •1.History of allergy to Daclatasvir, and Asunaprevir. 2.Decompensated liver cirrhosis 3.pregnant woman or lactating mother 4.Hepatocellular carcinoma, or other malignant tumor. 5.severe depression 6.Judged by investigator not to be appropriate for inclusion in this study
研究者
相似试验
已完成
不适用
Predictive factors associated with virological response in Ombitasvir/Paritaprevir/Ritonavir/Ribavirin combination therapy for genotype2a infected chronic hepatitis C patientsChronic hepatitis CJPRN-UMIN000026640ipppon Medical School Chiba Hokusoh Hospital98
已完成
不适用
Incidence and risk factors of viral infections in patients after liver transplantatioPatients undergoing orthotopic liver transplantation from deceased donorsK74.6C22.0Other and unspecified cirrhosis of liverLiver cell carcinomaDRKS00006754Klinik für Anaesthesiologie Universitätsklinikum Heidelberg51
招募中
不适用
Determinants of sustained virological response after discontinuation of long-term nucleoside analogue therapy in chronic hepatitis B patients.Hepatitis BACTRN12615001063505Professor Alexander Thompson200
已完成
不适用
Examination of virological response and predictive factors in Elbasvir/Grazoprevir combination therapy for genotype1 infected chronic hepatitis C patientsChronic hepatitis CJPRN-UMIN000029262ippon Medical School Chiba Hokusoh Hospital300
已完成
不适用
Immune response to oral vaccinesCTRI/2012/10/003057Centre for Health Research and Development Society for Applied Studies400